Related Experiment Video
Updated: Aug 6, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Genetic modifiers of muscular dystrophy: implications for therapy
Ahlke Heydemann1, Katherine R Doherty, Elizabeth M McNally
1Department of Medicine, Section of Cardiology, The University of Chicago, Chicago, IL 60637, USA.
Genetic research has identified over 25 genes causing muscular dystrophies. Studies in animal models reveal genetic modifiers influencing disease severity, offering potential therapeutic targets for muscular dystrophy.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Significant advancements in understanding muscular dystrophy genetics over the past 20 years.
- Over 25 genes identified as causes of muscular dystrophy, with numerous mutations described for each.
- Phenotypic variability in muscular dystrophies, even with identical mutations, affects both muscle and cardiac function.
Purpose of the Study:
- To explore the reasons behind phenotype variability in muscular dystrophies.
- To investigate the role of genetic background in modulating dystrophic phenotypes.
- To identify genetic modifier loci that influence muscular dystrophy progression.
Main Methods:
- Utilizing genetically engineered animal models (mice) with single mutations on inbred backgrounds.
- Analyzing phenotypic variation in relation to genetic background.
- Identifying specific genes acting as modifiers of muscular dystrophy.
Main Results:
- Genetic background significantly alters phenotypic variation in muscular dystrophy.
- Evidence for the presence of genetic modifier loci that can ameliorate or enhance dystrophic phenotypes.
- Several genes implicated as modifiers of muscular dystrophy through studies in mouse models.
Conclusions:
- Genetic modifiers play a crucial role in the phenotypic spectrum of muscular dystrophies.
- Understanding these modifiers is key to explaining disease variability.
- Identified pathways involving genetic modifiers hold potential for therapeutic interventions in muscular dystrophy.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Pharmacogenomics: Identification of New Drug Targets
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Sex-linked Disorders
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...

